Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Ordinary Share $0.00001 Par Value
- Total 13F shares
- 48,815,898
- Total 13F value
- $548,690,907
- Share change
- -2,031,356
- Put/Call ratio
- 0.09%
- SEC-reported price per share
- $11.24
- Number of holders
- 116
- Value change
- -$21,251,604
- Number of buys
- 42
- Number of sells
- 59
- Shares outstanding
- 51,428,000
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
116
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Weiss Asset Management LP
Disclosed value leader
Weiss Asset Management LP
Comparable rows
15/15
Latest evidence
30 Sep 2023
3/4/5
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
Weiss Asset Management LP leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Weiss Asset Management LP's linked filing trail.
Comparable ownership
Top 5
Weiss Asset Management LP
14%
BAUPOST GROUP LLC/MA
14%
Madison Avenue Partners, LP
14%
BlackRock Finance, Inc.
8.9%
VANGUARD GROUP INC
7.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Weiss Asset Management LP |
3/4/5
13F
10%+ Owner · Company
|
14%
from 13F
|
$76,733,147
7,457,060 shares
|
— | 19 Sep 2022 |
| BAUPOST GROUP LLC/MA |
13F
Company
|
14%
|
$64,028,000
7,419,226 shares
|
— | 30 Sep 2023 |
| Madison Avenue Partners, LP |
13F
Company
|
14%
|
$60,515,510
7,012,226 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
8.9%
|
$39,412,606
4,566,930 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
7.5%
|
$33,133,409
3,839,329 shares
|
— | 30 Sep 2023 |
| Irenic Capital Management LP |
13F
Company
|
5.4%
|
$23,826,981
2,760,948 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
116
Shares
48,815,898
Rows available
116
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
113
Q4 2023 holders
116
Holder diff
3
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|